Open-Label Extension Study of ASTORIA

Summary

This current open-label extension (OLE) study (JM-010CS-OL) will explore the safety and tolerability of long-term administration of JM-010 of patients who completed 12-week treatment of Phase 2 (JM-010CS03) study.

Timeline

Start

2024-01-19

Primary completion

2024-05-22

Completion

2024-06-27

Outcome

Outcome not reported

Stopped (Business): “The trial is terminated based on business decision, not due to safety concerns or regulatory requirements.”

Drugs

Indications